Daniel Kazado

Daniel Kazado discloses dealings in Immune Pharmaceuticals Inc to SEC (Form 4). Between 26 November 2014 and 4 January 2017, the trades on record add up to 7 filings.

Every open-market trade on record is a purchase: 6 purchases worth €500k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2017 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €47k. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 4 January 2017 with an open-market purchase (€14k) in Immune Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.